MacroGenics Provides Update on Corporate Progress and Third Quarter 2019 Financial Results

    NEXT STORY
    Sensus Healthcare Reports Third Quarter 2019 Financial Results
    PREV STORY
    American Gene Technologies Hosts Celebration Event For Its First IND Submission (For HIV) To The Food and Drug Administration (FDA)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunicum AB (publ) Announces Publication of Abstracts for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium

    author_avatar
    NASDAQ Market News

    Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38

    author_avatar
    NASDAQ Market News

    RedHill Biopharma to Host Analyst and Investor Webcast on TALICIA® for H. pylori infection on October 30, 2018

    Top-line results from the ERADICATE Hp2 confirmatory Phase III study expected before year-end 2018H. ...

    author_avatar
    NASDAQ Market News